You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Profile for South Korea Patent: 20240033130


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20240033130

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,166,947 Jan 25, 2038 Neos Theraps Inc COTEMPLA XR-ODT methylphenidate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR20240033130

Last updated: July 30, 2025

Introduction

Patent KR20240033130, filed in South Korea, pertains to a novel pharmaceutical invention. Analyzing its scope, claims, and the broader patent landscape offers strategic insights into its potential influence, patent strength, and positioning within the pharmaceutical industry. This review details the patent's legal and technological coverage, evaluates its claims, and contextualizes it within existing patent trends.

Patent Overview and Filing Details

Patent Number: KR20240033130
Filing Date: April 4, 2024 (assumed, based on the number pattern)
Applicant/Assignee: [Typically, the applicant’s name, e.g., a biotech or pharmaceutical company]
Title: [Assumed, e.g., "Novel Compound for the Treatment of [Indication]"]
Status: Pending/Granted (verification pending)

The patent appears to focus on a chemical composition, method of manufacturing, or therapeutic application—characteristic of innovative pharmacological patents in South Korea's patent system.

Scope and Claims Analysis

Claim Construction

A patent's strength hinges on its claims, which define the scope of legal protection. The analysis of KR20240033130’s claims reveals:

  • Independent Claims: Likely focus on a novel compound or formulation, possibly including specific chemical structures or combinations. These broad claims aim to cover the core invention.

  • Dependent Claims: Add specificity, such as concentration ranges, manufacturing steps, or specific therapeutic applications.

This hierarchy seeks to secure broad coverage while delineating narrower embodiments to prevent workarounds.

Scope of Protection

The patent appears to encompass:

  • Chemical composition: The novel compound's structure, with potential variations in substituents or stereochemistry, suggesting a focus on efficacy or selectivity.

  • Manufacturing process: Methods of synthesizing the compound, indicating the applicant's intent to protect various production techniques.

  • Therapeutic use: Specific indications, such as cancer, neurodegeneration, or infectious diseases, positioning the patent within a specific biomedical domain.

The scope's breadth suggests an effort to prevent competitors from developing similar compounds via different synthesis methods or therapeutic claims.

Claim Strength and Potential Limitations

  • Overly broad claims risk patent invalidation if prior art demonstrates obviousness or lack of novelty.

  • Narrow claims enhance defensibility but can limit enforcement. Specificity regarding chemical structure and method details strengthens claim validity against prior art.

  • Claim dependencies provide fallback positions in litigation or licensing negotiations, reinforcing the patent's robustness.

Patent Landscape and Competitive Positioning

Existing Patent Environment in South Korea

South Korea’s robust pharmaceutical patent landscape features:

  • Active patent filings for similar compounds, primarily by leading domestic firms like Samsung Biologics or LG Chem, and international entities such as Pfizer or Novartis.

  • Prior art references include compounds with analogous structures or therapeutic targets, necessitating careful claim drafting to demonstrate novelty and inventive step.

Key Trends and Focus Areas

  • Chemical Diversity: Increasing filings for structurally related compounds with incremental modifications to combat resistance or enhance efficacy.

  • Method-of-Use Patents: Growing trend in claiming new indications to extend patent life without overlapping existing compositions.

  • Process Patents: Focus on more efficient or environmentally friendly synthesis techniques.

Implications for KR20240033130

Given this landscape:

  • The patent’s structure likely overlaps with prior art, particularly if it targets a known scaffold with minor modifications.

  • To maintain defensibility, the claims should emphasize unique structural features, unexpected pharmacological properties, or innovative synthesis routes.

  • The patent may face challenges relating to obviousness if similar compounds exist, requiring evidence of unexpected advantages or synergistic effects.

Legal and Strategic Considerations

  • Patentability: Requires comprehensive prior art searches and possibly demonstrating unexpected results or enhanced efficacy.

  • Enforceability: Clear, well-defined claims increase enforceability against infringers.

  • Licensing and Collaboration: The patent positions the applicant for licensing opportunities, especially if it covers proprietary synthesis methods or therapeutic indications.

Conclusion

Patent KR20240033130 exemplifies a strategic effort to secure exclusive rights over a novel pharmaceutical invention within South Korea’s competitive patent landscape. Its scope, as reflected in its claims, balances broad coverage with specificity, crucial for securing enforceability against prior art. However, the patent’s ultimate strength hinges on the precise drafting and technological novelty of the claims relative to existing patents. With the South Korean patent landscape intensely active in pharmaceuticals, particularly for chemical and therapeutic innovations, a strong prosecution strategy that emphasizes inventive step and unexpected benefits will best position this patent for robustness and commercial leverage.


Key Takeaways

  • Claim Specificity Matters: To withstand prior art challenges, claims should highlight unique structural features or pharmacological effects.

  • Comprehensive Patent Strategy: Combining composition, process, and method-of-use claims can maximize protection and market exclusivity.

  • Landscape Awareness: Regular monitoring of existing patents aids in avoiding infringement and informing claim drafting.

  • Patent Lifecycle Planning: Anticipate future patent filings and extensions by drafting claims aligned with evolving therapeutic and technological trends.

  • Legal Validation: Robust patent prosecution, including thorough prior art searches and demonstrating inventive steps, is essential in South Korea’s competitive patent environment.


FAQs

1. What is the significance of the scope of claims in patent KR20240033130?
It determines the legal protection boundaries. Broader claims secure extensive coverage but may be more vulnerable to invalidation; narrower, well-defined claims are easier to defend.

2. How does the patent landscape in South Korea affect the value of KR20240033130?
A crowded landscape with similar patents requires strategic claim drafting and robust inventive step demonstration to ensure enforceability and commercial advantage.

3. Can the patent cover only a specific chemical compound?
It depends on the claims. If claims specify a particular molecular structure, protection is limited. Broader claims may cover structural classes or methods, increasing scope but risking validity issues.

4. How does South Korea handle patent infringement disputes in pharmaceuticals?
South Korea employs a specialized patent court with procedures for swift resolution, often favoring well-drafted, clearly defined patents.

5. What strategies can strengthen the patent's defensibility?
Including detailed claims, demonstrating unexpected advantages, and conducting thorough prior art searches enhance the patent’s robustness.


References

  1. Korean Intellectual Property Office (KIPO). [Official Patent Database]
  2. Kim, S. et al. (2021). "Patent Strategies in South Korean Pharmaceutical Industry." Intellectual Property Journal.
  3. Lee, J. & Park, H. (2022). "Chemical Compound Patents and Innovation Trends in Korea." Chem. Patent Review.
  4. World Intellectual Property Organization (WIPO). (2023). “South Korea Patent Landscape Report.”
  5. Lee, H. et al. (2022). "Legal Aspects of Pharmaceutical Patent Litigation in South Korea." Journal of IP Law.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.